The National Cancer Institute (NCI) is offering this grant to support the early-stage development of innovative technologies for biospecimen science. This initiative addresses pre-analytical variations in the collection, processing, handling, and storage of cancer-relevant biospecimens. The grant is for developing tools, devices, and methods to assess quality, preserve integrity, and establish robust quality control. Its purpose is to maximize the utility of biospecimens for downstream analyses, enhancing and accelerating research in cancer biology, prevention, diagnosis, treatment, epidemiology, and health disparities. Projects must include quantitative milestones.
Opportunity ID: 206215
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-13-003 |
| Funding Opportunity Title: | Early-Stage Development of Innovative Technologies for Biospecimen Science (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 09, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 20, 2013 |
| Current Closing Date for Applications: | Sep 20, 2013 |
| Archive Date: | Oct 21, 2013 |
| Estimated Total Program Funding: | $800,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Independent school districts County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses City or township governments Native American tribal governments (Federally recognized) Special district governments Private institutions of higher education Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on early-stage development of technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of cancer-relevant biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, prevention, diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. All projects must include quantitative milestones (i.e., technical metrics that determine whether the specific aims have been accomplished). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00151431 | Jan 20, 2013 | Sep 20, 2013 | View |
Package 1
Mandatory forms
206215 RR_SF424_1_2-1.2.pdf
206215 PerformanceSite_1_4-1.4.pdf
206215 RR_OtherProjectInfo_1_3-1.3.pdf
206215 RR_KeyPersonExpanded_1_2-1.2.pdf
206215 PHS398_CoverPageSupplement_1_4-1.4.pdf
206215 PHS398_ResearchPlan_1_3-1.3.pdf
206215 PHS398_Checklist_1_3-1.3.pdf
Optional forms
206215 RR_SubawardBudget30-1.2.pdf
206215 PHS398_ModularBudget_1_2-1.2.pdf
206215 RR_Budget-1.1.pdf
206215 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
